INTI
Inhibitor Therapeutics, Inc.
Phase 2
AI-extracted
itraconazole
Basal Cell Carcinoma Nevus Syndrome (BCCNS)
74d ago
Apr 24, 2026
SEC 8-K
verified 13h ago
Countdown card →